Variant report
Variant | nsv964074 |
---|---|
Chromosome Location | chr4:95286219-95292123 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:95281322..95284168-chr4:95287394..95289244,2 | K562 | blood: | |
2 | chr4:95285373..95288161-chr4:95288745..95292306,3 | K562 | blood: | |
3 | chr4:95266109..95267658-chr4:95291382..95293915,2 | K562 | blood: | |
4 | chr4:95287113..95289121-chr4:95292704..95294329,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SMARCAD1-1 | chr4:95290984-95291314 | NONHSAT097447 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000241103 | TF binding region |
ENSG00000241103 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs568873856 | chr4:95286275-95286276 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs373141994 | chr4:95286301-95286302 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs545989130 | chr4:95286321-95286322 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs555657189 | chr4:95286347-95286348 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs374670271 | chr4:95286349-95286350 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs548007513 | chr4:95286373-95286374 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs567884470 | chr4:95286409-95286410 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs368670360 | chr4:95286434-95286435 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs551116345 | chr4:95286489-95286490 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs149926912 | chr4:95286505-95286506 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs6419132 | chr4:95286541-95286542 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs553663230 | chr4:95286641-95286642 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs189133673 | chr4:95286645-95286646 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs192472909 | chr4:95286681-95286682 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs184471111 | chr4:95286734-95286735 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs367725984 | chr4:95286794-95286795 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs374921784 | chr4:95286798-95286799 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs145014513 | chr4:95286814-95286815 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs190185669 | chr4:95286834-95286835 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs142188521 | chr4:95286839-95286840 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs72888622 | chr4:95286870-95286871 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs144477947 | chr4:95286907-95286908 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs527424103 | chr4:95286952-95286953 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs540881673 | chr4:95286996-95286997 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs61457334 | chr4:95286999-95287000 | Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs529454185 | chr4:95287040-95287041 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs549343585 | chr4:95287041-95287042 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs371869019 | chr4:95287042-95287043 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs562580153 | chr4:95287045-95287046 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs578038460 | chr4:95287055-95287056 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs374652291 | chr4:95287065-95287066 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs78561283 | chr4:95287086-95287087 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs75642046 | chr4:95287108-95287109 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs570871984 | chr4:95287137-95287138 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs533550149 | chr4:95287138-95287139 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs181396447 | chr4:95287142-95287143 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs567240581 | chr4:95287155-95287156 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs545116690 | chr4:95287158-95287159 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs536433193 | chr4:95287204-95287205 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs372351258 | chr4:95287205-95287206 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs368410810 | chr4:95287283-95287284 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs141123881 | chr4:95287304-95287305 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs146942152 | chr4:95287314-95287315 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs560538381 | chr4:95287316-95287317 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs375412716 | chr4:95287321-95287322 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs537995637 | chr4:95287325-95287326 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs558285069 | chr4:95287378-95287379 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs527641447 | chr4:95287444-95287445 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs542923666 | chr4:95287460-95287461 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs186413654 | chr4:95287473-95287474 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Cancer | 19907438 | CNVD |
Prostate cancer | 16573809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:95284800-95287600 | Enhancers | HUVEC | blood vessel |
2 | chr4:95285000-95286600 | Weak transcription | NH-A | brain |
3 | chr4:95285600-95286600 | Weak transcription | Osteobl | bone |
4 | chr4:95286000-95287200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
5 | chr4:95286200-95287000 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr4:95286600-95286800 | Enhancers | Primary T helper memory cells from peripheral blood 1 | blood |
7 | chr4:95286600-95287000 | Enhancers | NH-A | brain |
8 | chr4:95286600-95287000 | Enhancers | Osteobl | bone |
9 | chr4:95290000-95290600 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr4:95291200-95291800 | Enhancers | Fetal Muscle Leg | muscle |
11 | chr4:95291200-95291800 | Enhancers | K562 | blood |
12 | chr4:95291800-95293200 | Weak transcription | Fetal Muscle Leg | muscle |
13 | chr4:95291800-95306200 | Weak transcription | K562 | blood |